Preventing Chronic Disease | Hospital Utilization, Costs, and Mortality for Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample, 2009 - CDC

full-text ►
Preventing Chronic Disease | Hospital Utilization, Costs, and Mortality for Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample, 2009 - CDC

 

Multiple Chronic Conditions Collection

This week Preventing Chronic Disease (PCD) released 8 articles focusing on multiple chronic conditions. The articles within this collection address the current trends in population growth, age distribution, and disease dynamics that forecast rises in the prevalence of chronic diseases, other chronic conditions, and combinations of chronic conditions.

 

Hospital Utilization, Costs, and Mortality for Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample, 2009

Navigate This Article

• Abstract
• Introduction
• Analysis
• Results
• Summary
• Acknowledgments
• Author Information
• References
• Tables
• Appendix

Claudia A. Steiner, MD, MPH; Bernard Friedman, PhD

Suggested citation for this article: Steiner CA, Friedman B. Hospital Utilization, Costs, and Mortality for Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample, 2009. Prev Chronic Dis 2013;10:120292. DOI: http://dx.doi.org/10.5888/pcd10.120292.

PEER REVIEWED

Abstract

Objective
Our objective was to provide a national estimate across all payers of the distribution and cost of selected chronic conditions for hospitalized adults in 2009, stratified by demographic characteristics.
Analysis
We analyzed the Nationwide Inpatient Sample (NIS), the largest all-payer inpatient database in the United States. Use, cost, and mortality estimates across payer, age, sex, and race/ethnicity are produced for grouped or multiple chronic conditions (MCC). The 5 most common dyads and triads were determined.
Results
In 2009, there were approximately 28 million adult discharges other than those related to pregnancy and maternity, from US hospitals; 39% had 2 to 3 MCC, and 33% had 4 or more. A higher number of MCC was associated with higher mortality, use of services, and average cost. The percentages of Medicaid, privately insured patients, and race groups with 4 or more MCC were highly sensitive to age.
Summary
This descriptive analysis of multipayer inpatient data provides a robust national view of the substantial use and costs among adults hospitalized with MCC.

Utilización de hospitales, costos y mortalidad de adultos con afecciones crónicas múltiples, muestra de pacientes hospitalizados en todo el país, 2009

Claudia A. Steiner, MD, MPH; Bernard Friedman, PhD

Citación sugerida para este artículo: Steiner CA, Friedman B. Hospital Utilization, Costs, and Mortality for Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample, 2009. Prev Chronic Dis 2013;10:120292. DOI: http://dx.doi.org/10.5888/pcd10.120292.

REVISADO POR EXPERTOS

Resumen

Objeto
Nuestro objeto fue proporcionar un cálculo nacional de la distribución y el costo de determinadas afecciones crónicas, en adultos hospitalizados en el 2009 para todos los pagadores, estratificados por características demográficas.
Método
Analizamos la Muestra nacional de pacientes hospitalizados (NIS, por sus siglas en inglés), la base de datos de pacientes hospitalizados más grande de los Estados Unidos para todos los pagadores. Se hicieron cálculos de utilización, costo y mortalidad en todos los grupos, por pagador, edad, sexo y raza/etnia para afecciones crónicas múltiples (MCC) o agrupadas. Se determinaron las 5 díadas y tríadas más frecuentes.
Resultados
En el 2009, se dieron aproximadamente 28 millones de altas hospitalarias de adultos en los EE. UU.; 39 % tenía de 2 a 3 MCC y el 33 % tenía 4 o más. Se relacionó tener un número mayor de MCC con mayor mortalidad, uso de servicios y costo promedio. Los porcentajes de pacientes de Medicaid, pacientes con seguro privado y de grupos raciales con 4 o más MCC fueron altamente sensibles a la edad.
Conclusión
Este análisis descriptivo de datos de pacientes hospitalizados de varios pagadores proporciona una perspectiva nacional robusta del significativo uso y de los costos entre los adultos hospitalizados con MCC.